Stannard, H.; Koszalka, P.; Deshpande, N.; Desjardins, Y.; Baz, M.
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 2023, 15, 2447.
https://doi.org/10.3390/v15122447
AMA Style
Stannard H, Koszalka P, Deshpande N, Desjardins Y, Baz M.
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses. 2023; 15(12):2447.
https://doi.org/10.3390/v15122447
Chicago/Turabian Style
Stannard, Harry, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, and Mariana Baz.
2023. "Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses" Viruses 15, no. 12: 2447.
https://doi.org/10.3390/v15122447
APA Style
Stannard, H., Koszalka, P., Deshpande, N., Desjardins, Y., & Baz, M.
(2023). Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses, 15(12), 2447.
https://doi.org/10.3390/v15122447